|
Press Release DOVEBID® TO CONDUCT 16th IN SERIES OF BIOPHARMA EXCHANGE AUCTIONS, FEATURING ASSETS OF PFIZER, INC. AND BRISTOL-MYERS SQUIBB COMPANY FOSTER CITY, CA (August 10, 2005) - DoveBid, Inc., a global provider of capital asset auction and valuation services, announced today it will conduct BioPharma Exchange #16, a two-day online auction featuring biotechnology and pharmaceutical research and development lab equipment from Pfizer, Inc. (NYSE: PFE), Bristol-Myers Squibb Company (NYSE: BMY), and other biotechnology companies. This sixteenth in a series of BioPharma Exchanges will be conducted over the Internet at DoveBid’s Website beginning on August 16, 2005 at 9:00 a.m. Pacific Time. This auction will feature a wide range of quality equipment, including a Perkin Elmer Imagetrak combination liquid handling/imaging system, X-ray diffraction data collection equipment, Niro Pharma Systems mini blender and IBC bins, lab equipment, and more. The BioPharma Exchange #16 is another example of DoveBid's Global Auction Exchange program, where multiple sellers consign assets together into auction events, to gain broad asset exposure to a global audience of buyers. Participants may bid online. Detailed preview information, asset catalog, and online bidding instructions are available at www.dovebid.com. For a complete list of our auctions, equipment asset catalogs, and brochures, please visit DoveBid’s Website at www.dovebid.com. About DoveBid® # # # DoveBid Contact: |
